Yue Yaqing, Mu Zhaoxia, Wang Xibo, Liu Yan
Department of Gynecology, First Affiliated Hospital of Shandong Second Medical University (Weifang People's Hospital), Weifang 261000, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Apr 20;45(4):837-843. doi: 10.12122/j.issn.1673-4254.2025.04.19.
To investigate the regulatory effects of Aurora-A in regulating proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of cervical cancer cells and the role of actin-related protein 2/3 complex subunit 4 (ARPC4) in mediating its effects.
The plasmids pCDH-NC, pCDH-Aurora-A, and shRNA-ARPC4 were used for inducing Aurora-A overexpression or ARPC4 knockdown in HeLa cells. The cells were divided into vector group, Aurora-A overexpression group, Aurora-A overexpression+ARPC4 knockdown group, and Aurora-A overexpression+NF‑κBp65 inhibitor group and transfected with the corresponding plasmids. The proliferation, colony-forming ability, migration and invasion of the treated Hela cells was evaluated using EdU immunofluorescence assay, crystal violet staining, scratch assay, Transwell assay, and Matrigel assay. Western blotting was performed to detect the changes in cellular expressions of EMT-related proteins and expression levels of NF-κBp65 and ARPC4.
The expression of ARPC4 was significantly decreased in HeLa cells with Aurora-A knockdown and increased in Aurora-A-overexpressing cells. Aurora-A overexpression obviously promoted proliferation, migration, and invasion abilities of HeLa cells, and these effects was significantly antagonized by ARPC4 knockdown. In Aurora-A-overexpressing cells, the phosphorylation level of NF-κBp65 and the expression level of ARPC4 were increased significantly, and application of the NF‑κBp65 inhibitor obviously lowered the expression level of ARPC4.
Aurora-A overexpression upregulates the expression of ARPC4 by activating the NF-κBp65 signaling pathway, thereby promoting migration, invasion and EMT of HeLa cells.
探讨Aurora-A对宫颈癌细胞增殖、迁移、侵袭及上皮-间质转化(EMT)的调控作用,以及肌动蛋白相关蛋白2/3复合体亚基4(ARPC4)在介导其作用中的作用。
采用质粒pCDH-NC、pCDH-Aurora-A和shRNA-ARPC4在HeLa细胞中诱导Aurora-A过表达或ARPC4敲低。将细胞分为载体组、Aurora-A过表达组、Aurora-A过表达+ARPC4敲低组和Aurora-A过表达+NF-κBp65抑制剂组,并用相应质粒进行转染。采用EdU免疫荧光检测、结晶紫染色、划痕实验、Transwell实验和基质胶实验评估处理后HeLa细胞的增殖、集落形成能力、迁移和侵袭能力。采用蛋白质免疫印迹法检测EMT相关蛋白的细胞表达变化以及NF-κBp65和ARPC4的表达水平。
在Aurora-A敲低的HeLa细胞中,ARPC4的表达显著降低,而在Aurora-A过表达的细胞中则升高。Aurora-A过表达明显促进了HeLa细胞的增殖、迁移和侵袭能力,而ARPC4敲低则显著拮抗了这些作用。在Aurora-A过表达的细胞中,NF-κBp65的磷酸化水平和ARPC4的表达水平显著升高,应用NF-κBp65抑制剂明显降低了ARPC4的表达水平。
Aurora-A过表达通过激活NF-κBp65信号通路上调ARPC4的表达,从而促进HeLa细胞的迁移、侵袭和EMT。